Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khalid Iqbal

Showing results (1-10 of 354) with videos related to

Pageof 36
Sort By:
Annals of Neurology|October 23, 2021
Thinking beyond the Aducanumab ControversyKhalid Iqbal
Cytoskeleton (Hoboken, N.J.)|December 21, 2023
Tau and Alzheimer's disease: Past, present and futureKhalid Iqbal
Journal of Alzheimer'S Disease : JAD|April 8, 2017
Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic CompoundNarjes Baazaoui, Khalid Iqbal
Alzheimer'S Research & Therapy|June 29, 2017
Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compoundNarjes Baazaoui, Khalid Iqbal
Biomolecules|October 27, 2022
Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic CompoundNarjes Baazaoui, Khalid Iqbal
Journal of Alzheimer'S Disease : JAD|March 23, 2018
A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic CompensationNarjes Baazaoui, Khalid Iqbal
Journal of Alzheimer'S Disease : JAD|May 23, 2022
COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term ConsequencesNarjes Baazaoui, Khalid Iqbal
Acta Neuropathologica|January 13, 2005
Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathiesKhalid Iqbal, Inge Grundke-Iqbal
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspectiveKhalid Iqbal, Inge Grundke-Iqbal
Acta Neuropathologica|October 1, 2011
Opportunities and challenges in developing Alzheimer disease therapeuticsKhalid Iqbal, Inge Grundke-Iqbal
Pageof 36

Showing results (1-10 of 354) with videos related to

Sort By:
Pageof 36
Annals of Neurology|October 23, 2021
Thinking beyond the Aducanumab ControversyKhalid Iqbal
Cytoskeleton (Hoboken, N.J.)|December 21, 2023
Tau and Alzheimer's disease: Past, present and futureKhalid Iqbal
Journal of Alzheimer'S Disease : JAD|April 8, 2017
Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic CompoundNarjes Baazaoui, Khalid Iqbal
Alzheimer'S Research & Therapy|June 29, 2017
Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compoundNarjes Baazaoui, Khalid Iqbal
Biomolecules|October 27, 2022
Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic CompoundNarjes Baazaoui, Khalid Iqbal
Journal of Alzheimer'S Disease : JAD|March 23, 2018
A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic CompensationNarjes Baazaoui, Khalid Iqbal
Journal of Alzheimer'S Disease : JAD|May 23, 2022
COVID-19 and Neurodegenerative Diseases: Prion-Like Spread and Long-Term ConsequencesNarjes Baazaoui, Khalid Iqbal
Acta Neuropathologica|January 13, 2005
Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathiesKhalid Iqbal, Inge Grundke-Iqbal
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspectiveKhalid Iqbal, Inge Grundke-Iqbal
Acta Neuropathologica|October 1, 2011
Opportunities and challenges in developing Alzheimer disease therapeuticsKhalid Iqbal, Inge Grundke-Iqbal
Pageof 36